DNA graphic

Funding

The Lupus Research Alliance seeks to fund biomedical research that will discover better diagnostics, improve medical treatments and advance translational and clinical research that will ultimately lead to a cure for lupus. The three grant mechanisms of the organization, Distinguished Innovator Award, Target Identification in Lupus and Novel Research Grant, provide distinct opportunities for researchers to test their most innovative hypothesis by applying cutting edge methodologies to further investigation in the lupus and autoimmune space.

The Distinguished Innovator Awards provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of systemic lupus erythematosus. The research proposal must aim to uncover the fundamental cause of lupus and present a compelling vision of how the discovery would lay the groundwork for a cure, prevention or highly effective therapy.

Currently, we are not accepting any applications for this grant mechanism. However, we encourage you to contact us if you are interested in receiving future requests for proposals.

Please contact Diomaris Gonzalez at dgonzalez@lupusresearch.org if you would like additional information or have any questions about this grant.

The Target Identification in Lupus grants provide up to $200,000/year total costs for up to 3 years. They support highly meritorious research focused on the identification and scientific and/or clinical advancement of therapeutic targets that will lead to new therapies for lupus.

Currently, we are not accepting any applications for this grant mechanism. However, we encourage you to contact us if you are interested in receiving future requests for proposals.

Please contact Diomaris Gonzalez at dgonzalez@lupusresearch.org if you would like additional information or have any questions about this grant.

 

Novel Research Grants offer up to $100,000/year total costs for up to 3 years. They provide early stage support for highly innovative approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches.

Currently, we are not accepting any applications for this grant mechanism. However, we encourage you to contact us if you are interested in receiving future requests for proposals.

Please contact Diomaris Gonzalez at dgonzalez@lupusresearch.org if you would like additional information or have any questions about this grant.

 

 

The purpose of the LuCIN Investigator Initiated Clinical Trial (IICT) grant is to provide support to one or more well justified investigator initiated clinical trial (not fully funded by industry or other sources). It is designed to determine whether, and to what extent, promising new therapies can improve the lives of lupus patients. A primary focus is the evaluation of drugs that are currently approved for other indications and are available for use, known as drug repurposing, which has been a major focus of the Lupus Research Alliance’s interest in drug development for lupus. The intention of this program is to eliminate the barriers that typically hinder lupus clinical trials, ensuring that scientifically-sound treatment approaches are tested in lupus patients as quickly as possible.

Please click on link below to apply:
https://proposalcentral.altum.com/default.asp

Learn and connect with our community!